- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7064 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
Patent holdings for IPC class A61K 31/7064
Total number of patents in this class: 601
10-year publication summary
|
46
|
54
|
52
|
51
|
55
|
54
|
44
|
42
|
26
|
14
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2207 |
18 |
| Prelude Therapeutics, Incorporated | 143 |
15 |
| Merck Sharp & Dohme LLC | 3737 |
14 |
| Arcus Biosciences, Inc. | 163 |
13 |
| Centre National de La Recherche Scientifique | 10914 |
11 |
| Emory University | 1712 |
9 |
| Société des Produits Nestlé S.A. | 10043 |
7 |
| The Regents of the University of California | 20590 |
7 |
| Chimerix, Inc. | 86 |
7 |
| OyaGen, Inc. | 19 |
7 |
| Tufts University | 340 |
7 |
| Washington University | 1716 |
7 |
| Merck Sharp & Dohme Corp. | 2183 |
6 |
| Vertex Pharmaceuticals Incorporated | 1589 |
6 |
| University of South Florida | 1877 |
6 |
| BioCryst Pharmaceuticals, Inc. | 180 |
6 |
| Idenix Pharmaceuticals LLC | 59 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
6 |
| Oric Pharmaceuticals, Inc. | 81 |
6 |
| Hoffmann-La Roche Inc. | 3726 |
5 |
| Other owners | 432 |